Evidence map›Paper›PMID 20980516›Full record

ArticleJournal of virology2011

B7-mediated costimulation of CD4 T cells constrains cytomegalovirus persistence.

Ramon Arens, Andrea Loewendorf, Min J Her, Kirsten Schneider-Ohrum, Geoffrey R Shellam, Edith Janssen, Carl F Ware, Stephen P Schoenberger, Chris A Benedict

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. The murine MHC-E molecule Qa-1Frontiers in immunology · 2026
    Article
  2. Article
  3. Article
  4. Cowpox virus encodes a protein that binds B7.1 and B7.2 and subverts T cell costimulation.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  5. Fuel and brake of memory T cell inflation.Medical microbiology and immunology · 2019
    Review
  6. The hallmarks of CMV-specific CD8 T-cell differentiation.Medical microbiology and immunology · 2019
    Review
  7. Cytomegalovirus: Shape-Shifting the Immune System.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Cytomegalovirus immune evasion of myeloid lineage cells.Medical microbiology and immunology · 2015
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Ramon ArensDivision of Developmental Immunology, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Andrea Loewendorf
Min J Her
Kirsten Schneider-Ohrum
Geoffrey R Shellam
Edith Janssen
Carl F Ware
Stephen P Schoenberger
Chris A Benedict
La Jolla Institute for Immunology · USCincinnati Children's Hospital Medical Center · USSanford Burnham Prebys Medical Discovery Institute · USUniversity of Pittsburgh · USUniversity of Western Australia · AU

Funding

Anti-herpesvirus Signaling by LTalphabeta/LIGHT CytokinesR01AI048073 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI WARE, CARL F · 2001 to 2016
$7.0M
Programming of CD8+ T Cell Tolerance by B Cell APCR01AI076972 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SCHOENBERGER, STEPHEN PHILIP · 2007 to 2011
$2.5M
Modulating Lymphotoxins for Viral DefensesR01AI057840 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI WARE, CARL F · 2005 to 2009
$2.4M
Activation of NKT cells by cytomegalovirusR21AI076864 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI BENEDICT, CHRISTOPHER A, KRONENBERG, MITCHELL · 2009 to 2010
$519k
CMV UL144 targets the HVEM-BTLA cosignaling systemR56AI069298 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI BENEDICT, CHRISTOPHER A · 2009 to 2009
$425k
NCI NIH HHS CA80261NIAID NIH HHS AI048073NIAID NIH HHS AI057840NIAID NIH HHS AI069298NIAID NIH HHS AI076864NIAID NIH HHS AI76972NIAID NIH HHS R01 AI048073NIAID NIH HHS R01 AI057840NIAID NIH HHS R01 AI076972NIAID NIH HHS R21 AI076864NIAID NIH HHS R56 AI069298
6 · The paper itself

Abstract

Cytomegalovirus (CMV) utilizes multiple strategies to modulate immunity and promote lifelong, persistent/latent infection, including suppressing T cell activation pathways. Here we examined the role of B7 costimulatory ligands in establishing immune détente from both the host and virus perspectives. Mice lacking both B7.1 and B7.2 showed reduced early expansion of CMV-specific CD4 T cells, consequently allowing for enhanced levels of persistent virus replication. In turn, a CMV mutant lacking expression of the m138 and m147.5 gene products, which restrict B7.1 and B7.2 expression in infected antigen-presenting cells, induced a more robust CD4 T cell response and showed decreased persistence. Together, these data reveal a requirement for B7-mediated signaling in regulating the CMV-specific CD4 T cell response and establishing host-virus equilibrium.

Indexed as

AnimalsB7-1 AntigenB7-2 AntigenCD4-Positive T-LymphocytesHerpesviridae InfectionsLymphocyte ActivationMiceMice, Inbred BALB CMice, Inbred C57BLMuromegalovirusVirus ReplicationB7-1 AntigenB7-2 AntigenCd86 protein, mouse

Identifiers

PMID20980516
PMCPMC3014178
OpenAlexW2149056352

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.